Position in AZN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,606,851
+$275,096 QoQ
Shares Held
45,390
+7.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#320
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RWA WEALTH PARTNERS, LLC holds $307,753,519 across 11 Drug Manufacturers - General names. AZN ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
387,249 | $98,349,628 | |
| 2 | LLY |
ELI LILLY & Co
|
76,026 | $91,187,872 | |
| 3 | ABBV |
AbbVie Inc.
|
235,826 | $59,343,254 | |
| 4 | AMGN |
Amgen Inc
|
48,114 | $17,423,041 | |
| 5 | MRK |
Merck & Co., Inc.
|
111,388 | $14,313,357 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
45,390 | $8,606,851 | |
| 7 | PFE |
Pfizer Inc
|
285,238 | $6,868,530 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
34,341 | $4,338,641 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,606,851 | 45,390 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,331,755 | 42,246 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||